Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VESICARE | Astellas Pharma | N-021518 RX | 2004-11-19 | 2 products, RLD, RS |
VESICARE LS | Astellas Pharma | N-209529 RX | 2020-05-26 | 1 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
overactive urinary bladder | EFO_1000781 | D053201 | N32.81 |
urge urinary incontinence | EFO_0006865 | D053202 | N39.41 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Solifenacin Succinate, Vesicare Ls, Astellas | |||
9918970 | 2031-05-18 | DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | 6 | 7 | 22 | 32 | 22 | 87 |
Urge urinary incontinence | D053202 | EFO_0006865 | N39.41 | 2 | 3 | 4 | 5 | 1 | 12 |
Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | 3 | 1 | 4 | 4 | — | 12 |
Urinary incontinence | D014549 | HP_0000020 | R32 | — | — | 2 | 7 | 2 | 11 |
Lower urinary tract symptoms | D059411 | EFO_0008008 | — | 2 | 2 | 3 | 3 | 1 | 11 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | — | 2 | — | 2 |
Neurogenic urinary bladder | D001750 | HP_0000011 | N31 | — | — | — | 2 | — | 2 |
Nocturia | D053158 | — | R35.1 | — | 1 | 1 | 1 | — | 2 |
Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | 1 | 1 | — | 2 |
Cognition | D003071 | EFO_0003925 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Urinary bladder diseases | D001745 | — | N32.9 | — | 1 | 4 | — | 1 | 6 |
Urologic diseases | D014570 | — | N39.9 | — | 1 | 2 | — | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 2 | — | — | — | 2 |
Urinary bladder neck obstruction | D001748 | EFO_1000840 | N32.0 | — | 1 | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | — | — | — | 1 |
Hot flashes | D019584 | — | — | — | 1 | — | — | — | 1 |
Signs and symptoms | D012816 | EFO_0003765 | R68 | — | 1 | — | — | — | 1 |
Urological manifestations | D020924 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 12 | — | — | — | — | 12 |
Pharmacokinetics | D010599 | — | — | 5 | — | — | — | — | 5 |
Drug interactions | D004347 | — | — | 3 | — | — | — | — | 3 |
Biological availability | D001682 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cross-sectional studies | D003430 | — | — | — | — | — | — | 1 | 1 |
Enuresis | D004775 | — | R32 | — | — | — | — | 1 | 1 |
Underactive urinary bladder | D000077295 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Solifenacin |
INN | solifenacin |
Description | Solifenacin is a member of isoquinolines. |
Classification | Small molecule |
Drug class | muscarinic receptor antagonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1 |
PDB | — |
CAS-ID | 242478-37-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1734 |
ChEBI ID | — |
PubChem CID | 154059 |
DrugBank | DB01591 |
UNII ID | A8910SQJ1U (ChemIDplus, GSRS) |